Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Signal Transduction and Targeted Therapy | CD3 and pMHC Bispecific Nanobody T Cell Engager Targeting Intracellular Tumor Antigens
2026-06-27
【Frontier Express】Translational Neurodegeneration | PirB Cleavage Drives Golgi-Directed Trafficking Deficits Underlying Neurodegeneration
2026-06-27
【Frontier Express】Antibodies | From Single Cells to Silicon: Emerging Technologies Transforming Monoclonal Antibody Discovery
2026-06-27
【Frontier Express】Antibodies | A Novel Monoclonal Antibody Targeting the A29 Protein of Monkeypox Virus and Its Application in Immunoassay
2026-06-27
【Frontier Express】Nature Communications | Stromal CD8+ TIL Density as a Negative Predictive Biomarker for Chemotherapy Response in ER+ HER2- Breast Cancer
2026-06-26
【Frontier Express】Cell | Multi-Adjuvant Personalized Neoantigen Vaccine Induces Potent T Cell Immunity in Melanoma
2026-06-26
【Frontier Express】Nature Communications | Roles of IL-1Ra and PGRN Autoantibodies in Dysregulated IL-1 and TNF Signaling Pathways in Severe COVID-19
2026-06-25






